CD Nomenclature 2015: Human Leukocyte Differentiation Antigen Workshops as a Driving Force in Immunology.
Identifieur interne : 002757 ( PubMed/Corpus ); précédent : 002756; suivant : 002758CD Nomenclature 2015: Human Leukocyte Differentiation Antigen Workshops as a Driving Force in Immunology.
Auteurs : Pablo Engel ; Laurence Boumsell ; Robert Balderas ; Armand Bensussan ; Valter Gattei ; Vaclav Horejsi ; Bo-Quan Jin ; Fabio Malavasi ; Frank Mortari ; Reinhard Schwartz-Albiez ; Hannes Stockinger ; Menno C. Van Zelm ; Heddy Zola ; Georgina ClarkSource :
- Journal of immunology (Baltimore, Md. : 1950) [ 1550-6606 ] ; 2015.
English descriptors
- KwdEn :
- MESH :
- chemical , classification : Antigens, CD.
- chemical , immunology : Antibodies, Monoclonal, Antigens, CD.
- chemical : Biomarkers.
- Humans, Terminology as Topic.
Abstract
CD (cluster of differentiation) Ags are cell surface molecules expressed on leukocytes and other cells relevant for the immune system. CD nomenclature has been universally adopted by the scientific community and is officially approved by the International Union of Immunological Societies and sanctioned by the World Health Organization. It provides a unified designation system for mAbs, as well as for the cell surface molecules that they recognize. This nomenclature was established by the Human Leukocyte Differentiation Antigens Workshops. In addition to defining the CD nomenclature, these workshops have been instrumental in identifying and determining the expression and function of cell surface molecules. Over the past 30 y, the data generated by the 10 Human Leukocyte Differentiation Antigens Workshops have led to the characterization and formal designation of more than 400 molecules. CD molecules are commonly used as cell markers, allowing the identification and isolation of leukocyte populations, subsets, and differentiation stages. mAbs against these molecules have proven to be essential for biomedical research and diagnosis, as well as in biotechnology. More recently, they have been recognized as invaluable tools for the treatment of several malignancies and autoimmune diseases. In this article, we describe how the CD nomenclature was established, present the official updated list of CD molecules, and provide a rationale for their usefulness in the 21st century.
DOI: 10.4049/jimmunol.1502033
PubMed: 26546687
Links to Exploration step
pubmed:26546687Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">CD Nomenclature 2015: Human Leukocyte Differentiation Antigen Workshops as a Driving Force in Immunology.</title><author><name sortKey="Engel, Pablo" sort="Engel, Pablo" uniqKey="Engel P" first="Pablo" last="Engel">Pablo Engel</name><affiliation><nlm:affiliation>Immunology Unit, Department of Cell Biology, Immunology, and Neurosciences, Medical School, University of Barcelona, Barcelona 08036, Spain; pengel@ub.edu.</nlm:affiliation></affiliation></author><author><name sortKey="Boumsell, Laurence" sort="Boumsell, Laurence" uniqKey="Boumsell L" first="Laurence" last="Boumsell">Laurence Boumsell</name><affiliation><nlm:affiliation>INSERM, Paris 75014, France;</nlm:affiliation></affiliation></author><author><name sortKey="Balderas, Robert" sort="Balderas, Robert" uniqKey="Balderas R" first="Robert" last="Balderas">Robert Balderas</name><affiliation><nlm:affiliation>BD Biosciences, San Jose, CA 95131;</nlm:affiliation></affiliation></author><author><name sortKey="Bensussan, Armand" sort="Bensussan, Armand" uniqKey="Bensussan A" first="Armand" last="Bensussan">Armand Bensussan</name><affiliation><nlm:affiliation>INSERM U976, Hospital Saint Louis, University of Paris, Paris 75010, France;</nlm:affiliation></affiliation></author><author><name sortKey="Gattei, Valter" sort="Gattei, Valter" uniqKey="Gattei V" first="Valter" last="Gattei">Valter Gattei</name><affiliation><nlm:affiliation>Clinical and Experimental Onco-Hematology Unit, Oncological Referral Center, Aviano 33081, Italy;</nlm:affiliation></affiliation></author><author><name sortKey="Horejsi, Vaclav" sort="Horejsi, Vaclav" uniqKey="Horejsi V" first="Vaclav" last="Horejsi">Vaclav Horejsi</name><affiliation><nlm:affiliation>Institute of Molecular Genetics, Czech Academy of Sciences, Prague 142 20, Czech Republic;</nlm:affiliation></affiliation></author><author><name sortKey="Jin, Bo Quan" sort="Jin, Bo Quan" uniqKey="Jin B" first="Bo-Quan" last="Jin">Bo-Quan Jin</name><affiliation><nlm:affiliation>Department of Immunology, The Fourth Military Medical University, Xi'an 710032, China;</nlm:affiliation></affiliation></author><author><name sortKey="Malavasi, Fabio" sort="Malavasi, Fabio" uniqKey="Malavasi F" first="Fabio" last="Malavasi">Fabio Malavasi</name><affiliation><nlm:affiliation>Laboratory of Immunogenetics and Center for Experimental Research and Medical Studies, Department of Medical Sciences, University of Turin, Turin 10126, Italy;</nlm:affiliation></affiliation></author><author><name sortKey="Mortari, Frank" sort="Mortari, Frank" uniqKey="Mortari F" first="Frank" last="Mortari">Frank Mortari</name><affiliation><nlm:affiliation>R&D Systems, Bio-Techne Corporation, Minneapolis, MN 55413;</nlm:affiliation></affiliation></author><author><name sortKey="Schwartz Albiez, Reinhard" sort="Schwartz Albiez, Reinhard" uniqKey="Schwartz Albiez R" first="Reinhard" last="Schwartz-Albiez">Reinhard Schwartz-Albiez</name><affiliation><nlm:affiliation>Tumor Immunology Program, German Cancer Research Center, Heidelberg 69120, Germany;</nlm:affiliation></affiliation></author><author><name sortKey="Stockinger, Hannes" sort="Stockinger, Hannes" uniqKey="Stockinger H" first="Hannes" last="Stockinger">Hannes Stockinger</name><affiliation><nlm:affiliation>Institute for Hygiene and Applied Immunology, Centre for Pathophysiology, Infectiology, and Immunology, Medical University of Vienna, Vienna 1090, Austria;</nlm:affiliation></affiliation></author><author><name sortKey="Van Zelm, Menno C" sort="Van Zelm, Menno C" uniqKey="Van Zelm M" first="Menno C" last="Van Zelm">Menno C. Van Zelm</name><affiliation><nlm:affiliation>Department of Immunology, Central Clinical School, Monash University, Melbourne, Victoria 3004, Australia;</nlm:affiliation></affiliation></author><author><name sortKey="Zola, Heddy" sort="Zola, Heddy" uniqKey="Zola H" first="Heddy" last="Zola">Heddy Zola</name><affiliation><nlm:affiliation>Child Health Research Institute and University of Adelaide, Adelaide 5000, Australia; and.</nlm:affiliation></affiliation></author><author><name sortKey="Clark, Georgina" sort="Clark, Georgina" uniqKey="Clark G" first="Georgina" last="Clark">Georgina Clark</name><affiliation><nlm:affiliation>Dendritic Cell Research, Australian and New Zealand Army Corps Research Institute, University of Sydney, Sydney 2139, Australia.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:26546687</idno><idno type="pmid">26546687</idno><idno type="doi">10.4049/jimmunol.1502033</idno><idno type="wicri:Area/PubMed/Corpus">002757</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002757</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">CD Nomenclature 2015: Human Leukocyte Differentiation Antigen Workshops as a Driving Force in Immunology.</title><author><name sortKey="Engel, Pablo" sort="Engel, Pablo" uniqKey="Engel P" first="Pablo" last="Engel">Pablo Engel</name><affiliation><nlm:affiliation>Immunology Unit, Department of Cell Biology, Immunology, and Neurosciences, Medical School, University of Barcelona, Barcelona 08036, Spain; pengel@ub.edu.</nlm:affiliation></affiliation></author><author><name sortKey="Boumsell, Laurence" sort="Boumsell, Laurence" uniqKey="Boumsell L" first="Laurence" last="Boumsell">Laurence Boumsell</name><affiliation><nlm:affiliation>INSERM, Paris 75014, France;</nlm:affiliation></affiliation></author><author><name sortKey="Balderas, Robert" sort="Balderas, Robert" uniqKey="Balderas R" first="Robert" last="Balderas">Robert Balderas</name><affiliation><nlm:affiliation>BD Biosciences, San Jose, CA 95131;</nlm:affiliation></affiliation></author><author><name sortKey="Bensussan, Armand" sort="Bensussan, Armand" uniqKey="Bensussan A" first="Armand" last="Bensussan">Armand Bensussan</name><affiliation><nlm:affiliation>INSERM U976, Hospital Saint Louis, University of Paris, Paris 75010, France;</nlm:affiliation></affiliation></author><author><name sortKey="Gattei, Valter" sort="Gattei, Valter" uniqKey="Gattei V" first="Valter" last="Gattei">Valter Gattei</name><affiliation><nlm:affiliation>Clinical and Experimental Onco-Hematology Unit, Oncological Referral Center, Aviano 33081, Italy;</nlm:affiliation></affiliation></author><author><name sortKey="Horejsi, Vaclav" sort="Horejsi, Vaclav" uniqKey="Horejsi V" first="Vaclav" last="Horejsi">Vaclav Horejsi</name><affiliation><nlm:affiliation>Institute of Molecular Genetics, Czech Academy of Sciences, Prague 142 20, Czech Republic;</nlm:affiliation></affiliation></author><author><name sortKey="Jin, Bo Quan" sort="Jin, Bo Quan" uniqKey="Jin B" first="Bo-Quan" last="Jin">Bo-Quan Jin</name><affiliation><nlm:affiliation>Department of Immunology, The Fourth Military Medical University, Xi'an 710032, China;</nlm:affiliation></affiliation></author><author><name sortKey="Malavasi, Fabio" sort="Malavasi, Fabio" uniqKey="Malavasi F" first="Fabio" last="Malavasi">Fabio Malavasi</name><affiliation><nlm:affiliation>Laboratory of Immunogenetics and Center for Experimental Research and Medical Studies, Department of Medical Sciences, University of Turin, Turin 10126, Italy;</nlm:affiliation></affiliation></author><author><name sortKey="Mortari, Frank" sort="Mortari, Frank" uniqKey="Mortari F" first="Frank" last="Mortari">Frank Mortari</name><affiliation><nlm:affiliation>R&D Systems, Bio-Techne Corporation, Minneapolis, MN 55413;</nlm:affiliation></affiliation></author><author><name sortKey="Schwartz Albiez, Reinhard" sort="Schwartz Albiez, Reinhard" uniqKey="Schwartz Albiez R" first="Reinhard" last="Schwartz-Albiez">Reinhard Schwartz-Albiez</name><affiliation><nlm:affiliation>Tumor Immunology Program, German Cancer Research Center, Heidelberg 69120, Germany;</nlm:affiliation></affiliation></author><author><name sortKey="Stockinger, Hannes" sort="Stockinger, Hannes" uniqKey="Stockinger H" first="Hannes" last="Stockinger">Hannes Stockinger</name><affiliation><nlm:affiliation>Institute for Hygiene and Applied Immunology, Centre for Pathophysiology, Infectiology, and Immunology, Medical University of Vienna, Vienna 1090, Austria;</nlm:affiliation></affiliation></author><author><name sortKey="Van Zelm, Menno C" sort="Van Zelm, Menno C" uniqKey="Van Zelm M" first="Menno C" last="Van Zelm">Menno C. Van Zelm</name><affiliation><nlm:affiliation>Department of Immunology, Central Clinical School, Monash University, Melbourne, Victoria 3004, Australia;</nlm:affiliation></affiliation></author><author><name sortKey="Zola, Heddy" sort="Zola, Heddy" uniqKey="Zola H" first="Heddy" last="Zola">Heddy Zola</name><affiliation><nlm:affiliation>Child Health Research Institute and University of Adelaide, Adelaide 5000, Australia; and.</nlm:affiliation></affiliation></author><author><name sortKey="Clark, Georgina" sort="Clark, Georgina" uniqKey="Clark G" first="Georgina" last="Clark">Georgina Clark</name><affiliation><nlm:affiliation>Dendritic Cell Research, Australian and New Zealand Army Corps Research Institute, University of Sydney, Sydney 2139, Australia.</nlm:affiliation></affiliation></author></analytic><series><title level="j">Journal of immunology (Baltimore, Md. : 1950)</title><idno type="eISSN">1550-6606</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antibodies, Monoclonal (immunology)</term><term>Antigens, CD (classification)</term><term>Antigens, CD (immunology)</term><term>Biomarkers</term><term>Humans</term><term>Terminology as Topic</term></keywords><keywords scheme="MESH" type="chemical" qualifier="classification" xml:lang="en"><term>Antigens, CD</term></keywords><keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Antibodies, Monoclonal</term><term>Antigens, CD</term></keywords><keywords scheme="MESH" type="chemical" xml:lang="en"><term>Biomarkers</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Humans</term><term>Terminology as Topic</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">CD (cluster of differentiation) Ags are cell surface molecules expressed on leukocytes and other cells relevant for the immune system. CD nomenclature has been universally adopted by the scientific community and is officially approved by the International Union of Immunological Societies and sanctioned by the World Health Organization. It provides a unified designation system for mAbs, as well as for the cell surface molecules that they recognize. This nomenclature was established by the Human Leukocyte Differentiation Antigens Workshops. In addition to defining the CD nomenclature, these workshops have been instrumental in identifying and determining the expression and function of cell surface molecules. Over the past 30 y, the data generated by the 10 Human Leukocyte Differentiation Antigens Workshops have led to the characterization and formal designation of more than 400 molecules. CD molecules are commonly used as cell markers, allowing the identification and isolation of leukocyte populations, subsets, and differentiation stages. mAbs against these molecules have proven to be essential for biomedical research and diagnosis, as well as in biotechnology. More recently, they have been recognized as invaluable tools for the treatment of several malignancies and autoimmune diseases. In this article, we describe how the CD nomenclature was established, present the official updated list of CD molecules, and provide a rationale for their usefulness in the 21st century.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26546687</PMID><DateCreated><Year>2015</Year><Month>11</Month><Day>07</Day></DateCreated><DateCompleted><Year>2016</Year><Month>03</Month><Day>22</Day></DateCompleted><DateRevised><Year>2015</Year><Month>11</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1550-6606</ISSN><JournalIssue CitedMedium="Internet"><Volume>195</Volume><Issue>10</Issue><PubDate><Year>2015</Year><Month>Nov</Month><Day>15</Day></PubDate></JournalIssue><Title>Journal of immunology (Baltimore, Md. : 1950)</Title><ISOAbbreviation>J. Immunol.</ISOAbbreviation></Journal><ArticleTitle>CD Nomenclature 2015: Human Leukocyte Differentiation Antigen Workshops as a Driving Force in Immunology.</ArticleTitle><Pagination><MedlinePgn>4555-63</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4049/jimmunol.1502033</ELocationID><Abstract><AbstractText>CD (cluster of differentiation) Ags are cell surface molecules expressed on leukocytes and other cells relevant for the immune system. CD nomenclature has been universally adopted by the scientific community and is officially approved by the International Union of Immunological Societies and sanctioned by the World Health Organization. It provides a unified designation system for mAbs, as well as for the cell surface molecules that they recognize. This nomenclature was established by the Human Leukocyte Differentiation Antigens Workshops. In addition to defining the CD nomenclature, these workshops have been instrumental in identifying and determining the expression and function of cell surface molecules. Over the past 30 y, the data generated by the 10 Human Leukocyte Differentiation Antigens Workshops have led to the characterization and formal designation of more than 400 molecules. CD molecules are commonly used as cell markers, allowing the identification and isolation of leukocyte populations, subsets, and differentiation stages. mAbs against these molecules have proven to be essential for biomedical research and diagnosis, as well as in biotechnology. More recently, they have been recognized as invaluable tools for the treatment of several malignancies and autoimmune diseases. In this article, we describe how the CD nomenclature was established, present the official updated list of CD molecules, and provide a rationale for their usefulness in the 21st century.</AbstractText><CopyrightInformation>Copyright © 2015 by The American Association of Immunologists, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Engel</LastName><ForeName>Pablo</ForeName><Initials>P</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-8410-252X</Identifier><AffiliationInfo><Affiliation>Immunology Unit, Department of Cell Biology, Immunology, and Neurosciences, Medical School, University of Barcelona, Barcelona 08036, Spain; pengel@ub.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boumsell</LastName><ForeName>Laurence</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>INSERM, Paris 75014, France;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balderas</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>BD Biosciences, San Jose, CA 95131;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bensussan</LastName><ForeName>Armand</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>INSERM U976, Hospital Saint Louis, University of Paris, Paris 75010, France;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gattei</LastName><ForeName>Valter</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Clinical and Experimental Onco-Hematology Unit, Oncological Referral Center, Aviano 33081, Italy;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horejsi</LastName><ForeName>Vaclav</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Institute of Molecular Genetics, Czech Academy of Sciences, Prague 142 20, Czech Republic;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Bo-Quan</ForeName><Initials>BQ</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-6386-7475</Identifier><AffiliationInfo><Affiliation>Department of Immunology, The Fourth Military Medical University, Xi'an 710032, China;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malavasi</LastName><ForeName>Fabio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Laboratory of Immunogenetics and Center for Experimental Research and Medical Studies, Department of Medical Sciences, University of Turin, Turin 10126, Italy;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mortari</LastName><ForeName>Frank</ForeName><Initials>F</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-3367-4998</Identifier><AffiliationInfo><Affiliation>R&D Systems, Bio-Techne Corporation, Minneapolis, MN 55413;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schwartz-Albiez</LastName><ForeName>Reinhard</ForeName><Initials>R</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-7741-2482</Identifier><AffiliationInfo><Affiliation>Tumor Immunology Program, German Cancer Research Center, Heidelberg 69120, Germany;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stockinger</LastName><ForeName>Hannes</ForeName><Initials>H</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-6404-4430</Identifier><AffiliationInfo><Affiliation>Institute for Hygiene and Applied Immunology, Centre for Pathophysiology, Infectiology, and Immunology, Medical University of Vienna, Vienna 1090, Austria;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Zelm</LastName><ForeName>Menno C</ForeName><Initials>MC</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-4161-1919</Identifier><AffiliationInfo><Affiliation>Department of Immunology, Central Clinical School, Monash University, Melbourne, Victoria 3004, Australia;</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zola</LastName><ForeName>Heddy</ForeName><Initials>H</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-0664-6518</Identifier><AffiliationInfo><Affiliation>Child Health Research Institute and University of Adelaide, Adelaide 5000, Australia; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clark</LastName><ForeName>Georgina</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Dendritic Cell Research, Australian and New Zealand Army Corps Research Institute, University of Sydney, Sydney 2139, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Immunol</MedlineTA><NlmUniqueID>2985117R</NlmUniqueID><ISSNLinking>0022-1767</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000911">Antibodies, Monoclonal</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015703">Antigens, CD</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>AIM</CitationSubset><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000911" MajorTopicYN="N">Antibodies, Monoclonal</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015703" MajorTopicYN="N">Antigens, CD</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="Y">classification</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009626" MajorTopicYN="Y">Terminology as Topic</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>11</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>11</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>3</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26546687</ArticleId><ArticleId IdType="pii">195/10/4555</ArticleId><ArticleId IdType="doi">10.4049/jimmunol.1502033</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002757 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 002757 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:26546687
|texte= CD Nomenclature 2015: Human Leukocyte Differentiation Antigen Workshops as a Driving Force in Immunology.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:26546687" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |